Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00983398
Title Melphalan, Carboplatin, and Sodium Thiosulfate for Patients With Central Nervous System (CNS) Embryonal or Germ Cell Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors OHSU Knight Cancer Institute
Indications

germ cell cancer

atypical teratoid rhabdoid tumor

childhood embryonal tumor with multilayered rosettes, C19MC-altered

pineoblastoma

neuroectodermal tumor

medulloepithelioma

medulloblastoma

Therapies

Pegfilgrastim

Filgrastim

Carboplatin + Melphalan

Age Groups: adult | child
Covered Countries USA

Facility Status City State Zip Country Details
University of Minnesota/Masonic Cancer Center Minneapolis Minnesota 55455 United States Details
OHSU Knight Cancer Institute Portland Oregon 97239 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field